ConjuChem files for bankruptcy
This article was originally published in Scrip
Executive Summary
ConjuChem Biotechnologies has become the latest biotech to succumb to the pressures of the economic downturn, filing a voluntary assignment in bankruptcy under Canada's Bankruptcy and Insolvency Act.